MANILA, Philippines — The safety of CoronaVac, the COVID-19 vaccine developed by China-based Sinovac BioTech, showed “remarkable” results across all age groups, including the elderly, according to Dr. Nina Gloriani, the head of the vaccine development expert panel of the Department of Science and Technology (DOST).
“Clinical trial findings showed that the Sinovac’s CoronaVac is well tolerated among older individuals,” Gloriani said in a media forum on Tuesday.
Gloriani then disclosed some details of the panel’s recommendation on the use of CoronaVac for senior citizens amid the lack of supply of AstraZeneca’s vaccine.
But last February, when the Food and Drug Administration (F…
Keep on reading: CoronaVac safety ‘remarkable’ across all age groups, including elderly – expert panel head